Abstract
Background
The long-term outcomes of post-colonoscopy colorectal cancer have varied in previous studies. Our nationwide cohort analysis estimated expected years of life lost to adjust for lead time bias.
Aim
We recalculated the long-term outcomes for post-colonoscopy and detected colorectal cancer.
Methods
Patients with colorectal cancer registered in the Taiwan Cancer Registry between 2002 and 2009 were enrolled. The detected group included 22,169 cases of colorectal cancer confirmed within 6 months after a colonoscopy. The post-colonoscopy group included 1653 cancer patients who received a colonoscopy 6–60 months before diagnosis. Patients were followed up until 2011. We simulated age-, sex-, and calendar year-matched referents from life tables in the Taiwan National Vital Statistics using a Monte Carlo method. The life expectancy and expected years of life lost of the cancer patients were obtained from extrapolation of the logit transformation of the survival ratio between the cancer cohorts and the referent groups.
Results
Post-colonoscopy colorectal cancer had shorter life expectancies than detected cancer (stages 2–4: 13.6 vs. 16.1 years; 8.7 vs. 12.6 years; 2.1 vs. 4.1 years, p < 0.001). The loss-of-life expectancy did not show this trend after adjusting for lead time bias. Post-colonoscopy colorectal cancer was found at an older age, more often proximal, and was associated with previous endoscopic polypectomy procedures (p < 0.001).
Conclusions
Post-colonoscopy colorectal cancer leads to a shorter life expectancy, which appears partially explained by the presence of lead time bias. Quality assurance for colonoscopy and close surveillance for high risk groups would reduce post-colonoscopy colorectal cancer.
Similar content being viewed by others
Abbreviations
- DCRC:
-
Detected colorectal cancer
- EYLL:
-
Expected years of life lost
- LE:
-
Life expectancy
- NHIRD:
-
National Health Insurance Research Database
- PCCRC:
-
Post-colonoscopy colorectal cancer
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Department of statistics. Statistics on the causes of death, 2017. Taiwan: ministry of health and welfare, the Executive Yuan. https://www.mohw.gov.tw/cp-3961-41763-2.html; 2018 Accessed 06.07. 2018.
Health Promotion administration, Ministry of Health and Welfare, the Executive Yuan. https://www.hpa.gov.tw/Pages/List.aspx?nodeid=269; 2015 Accessed 06.07. 2018.
Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.
Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.
Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med. 2011;154:22–30.
Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program. Cancer. 2015;121:3221–3229.
Govindarajan A, Rabeneck L, Yun L, Tinmouth J, Paszat LF, Baxter NN. Population-based assessment of the outcomes in patients with postcolonoscopy colorectal cancers. Gut. 2016;65:971–976.
Samadder NJ, Curtin K, Tuohy TM, et al. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology. 2014;46:950–960.
Farrar WD, Sawhney MS, Nelson DB, Lederle FA, Bond JH. Colorectal cancers found after a complete colonoscopy. Clin Gastroenterol Hepatol. 2006;4:1259–1264.
Cheung D, Evison F, Patel P, Trudgill N. Factors associated with colorectal cancer occurrence after colonoscopy that did not diagnose colorectal cancer. Gastrointest Endosc. 2016;84:287–295.
Sanduleanu S, Masclee AM, Meijer GA. Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol. 2012;9:550–554.
Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105:1189–1195.
Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;42:1–10.
Singh H, Nugent Z, Demers AA, Bernstein CN. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010;105:2588–2596.
Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96–102.
Erichsen R, Baron JA, Stoffel EM, Laurberg S, Sandler RS, Sørensen HT. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol. 2013;108:1332–1340.
Baxter NN, Sutradhar R, Forbes SS, Paszat LF, Saskin R, Rabeneck L. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011;140:65–72.
Cooper GS, Xu F, Barnholtz Sloan JS, Schluchter MD, Koroukian SM. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer. 2012;118:3044–3052.
Facciorusso A, Ferrusquía J, Muscatiello N. Lead time bias in estimating survival outcomes. Gut. 2016;65:538–539.
Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med. 1999;8:1627–1640.
Fang CT, Chang YY, Hsu HM, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM-Int J Med. 2007;100:97–105.
Chen WY, Cheng HC, Wang JD, Sheu BS. Factors that affect life expectancy of patients with gastric adenocarcinoma. Clin Gastroenterol Hepatol. 2013;11:1595–1600.
Chen PC, Lee JC, Wang JD. Estimation of life-year loss and lifetime costs for different stages of colon adenocarcinoma in Taiwan. PLoS One. 2015;10:e0133755.
Yang SC, Lai WW, Lin CC, et al. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan. Lung Cancer. 2017;108:183–191.
Health Promotion Administration, Ministry of Health and Welfare, the Executive Yuan. https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=615&pid=1126; 2018 Accessed 06.07. 2018.
Jackson C, Stevens J, Ren S, et al. Extrapolating survival from randomized trials using external data: a review of methods. Med Dec Mak. 2017;37:377–390.
Chu PC, Wang JD, Hwang JS, Chang YY. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates. Value Health. 2008;11:1102–1109.
Rutter MD, Beintaris I, Valori R, et al. World endoscopy organization consensus statements on post-colonoscopy and post-imaging colorectal cancer. Gastroenterology. 2018;155:909. https://doi.org/10.1053/j.gastro.2018.05.038.
Acknowledgments
This study was funded in part by grants from the Ministry of Science and Technology, Taiwan (MOST 105-2314-B-006-026, MOST 107-2627-M-006-007), and by National Cheng Kung University Hospital (NCKUH-10504002). No pharmaceutical company paid to have this article written.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, WY., Cheng, HC., Cheng, WC. et al. Lead Time Bias May Contribute to the Shorter Life Expectancy in Post-colonoscopy Colorectal Cancer. Dig Dis Sci 64, 2622–2630 (2019). https://doi.org/10.1007/s10620-019-05566-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-05566-x